Evidence map›Paper›PMID 26587021›Full record

ArticleAdvances in virology2015

Measles Virus: Identification in the M Protein Primary Sequence of a Potential Molecular Marker for Subacute Sclerosing Panencephalitis.

Hasan Kweder, Michelle Ainouze, Joanna Brunel, Denis Gerlier, Evelyne Manet, Robin Buckland

Open access · goldAbstract read
In one paragraph

Article in Advances in virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Subacute sclerosing panencephalitis - current perspectives.Pediatric health, medicine and therapeutics · 2018
    Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hasan KwederCIRI, International Center for Infectiology Research, Université de Lyon, 69007 Lyon, France ; Inserm, U1111, 69007 Lyon, France ; Ecole Normale Supérieure de Lyon, 69007 Lyon, France ; Centre International de Recherche en Infectiologie, Université Lyon 1, 69007 Lyon, France ; CNRS, UMR 5308, Lyon, France.
Michelle AinouzeCIRI, International Center for Infectiology Research, Université de Lyon, 69007 Lyon, France ; Inserm, U1111, 69007 Lyon, France ; Ecole Normale Supérieure de Lyon, 69007 Lyon, France ; Centre International de Recherche en Infectiologie, Université Lyon 1, 69007 Lyon, France ; CNRS, UMR 5308, Lyon, France.
Joanna BrunelCIRI, International Center for Infectiology Research, Université de Lyon, 69007 Lyon, France ; Inserm, U1111, 69007 Lyon, France ; Ecole Normale Supérieure de Lyon, 69007 Lyon, France ; Centre International de Recherche en Infectiologie, Université Lyon 1, 69007 Lyon, France ; CNRS, UMR 5308, Lyon, France.
Denis GerlierCIRI, International Center for Infectiology Research, Université de Lyon, 69007 Lyon, France ; Inserm, U1111, 69007 Lyon, France ; Ecole Normale Supérieure de Lyon, 69007 Lyon, France ; Centre International de Recherche en Infectiologie, Université Lyon 1, 69007 Lyon, France ; CNRS, UMR 5308, Lyon, France.
Evelyne ManetCIRI, International Center for Infectiology Research, Université de Lyon, 69007 Lyon, France ; Inserm, U1111, 69007 Lyon, France ; Ecole Normale Supérieure de Lyon, 69007 Lyon, France ; Centre International de Recherche en Infectiologie, Université Lyon 1, 69007 Lyon, France ; CNRS, UMR 5308, Lyon, France.
Robin BucklandCIRI, International Center for Infectiology Research, Université de Lyon, 69007 Lyon, France ; Inserm, U1111, 69007 Lyon, France ; Ecole Normale Supérieure de Lyon, 69007 Lyon, France ; Centre International de Recherche en Infectiologie, Université Lyon 1, 69007 Lyon, France ; CNRS, UMR 5308, Lyon, France.
Université Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subacute Sclerosing Panencephalitis (SSPE), a rare lethal disease of children and young adults due to persistence of measles virus (MeV) in the brain, is caused by wild type (wt) MeV. Why MeV vaccine strains never cause SSPE is completely unknown. Hypothesizing that this phenotypic difference could potentially be represented by a molecular marker, we compared glycoprotein and matrix (M) genes from SSPE cases with those from the Moraten vaccine strain, searching for differential structural motifs. We observed that all known SSPE viruses have residues P64, E89, and A209 (PEA) in their M proteins whereas the equivalent residues for vaccine strains are either S64, K89, and T209 (SKT) as in Moraten or PKT. Through the construction of MeV recombinants, we have obtained evidence that the wt MeV-M protein PEA motif, in particular A209, is linked to increased viral spread. Importantly, for the 10 wt genotypes (of 23) that have had their M proteins sequenced, 9 have the PEA motif, the exception being B3, which has PET. Interestingly, cases of SSPE caused by genotype B3 have yet to be reported. In conclusion, our results strongly suggest that the PEA motif is a molecular marker for wt MeV at risk to cause SSPE.

Identifiers

PMID26587021
PMCPMC4637438
OpenAlexW1917386426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.